120 related articles for article (PubMed ID: 76898)
1. 'One-alpha'.
Lancet; 1978 May; 1(8071):973-4. PubMed ID: 76898
[No Abstract] [Full Text] [Related]
2. Treatment of renal bone disease.
Lancet; 1979 Dec 22-29; 2(8156-8157):1339-40. PubMed ID: 92678
[No Abstract] [Full Text] [Related]
3. [Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].
von Herrath D; Kraft D; Schaefer K; Krempien B
MMW Munch Med Wochenschr; 1974 Sep; 116(37):1573-8. PubMed ID: 4374654
[No Abstract] [Full Text] [Related]
4. Histopathology of renal osteodystrophy with particular reference to the effects of 1alpha-hydroxyvitamin D3 in patients treated by long-term haemodialysis.
Ellis HA; Pierides AM; Feest TG; Ward MK; Kerr DN
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():31s-38s. PubMed ID: 606422
[TBL] [Abstract][Full Text] [Related]
5. Skeletal response to treatment with 1,25-dihydroxyvitamin D in renal failure.
Sherrard DJ; Coburn JW; Brickman AS; Singer FR; Maloney N
Contrib Nephrol; 1980; 18():92-7. PubMed ID: 7353382
[No Abstract] [Full Text] [Related]
6. Clinical effects of 1,25-dihydroxyvitamin D3 in uremic patients with overt osteodystrophy.
Brickman AS; Coburn JW; Sherrard DJ; Wong EG; Norman AW; Singer FR
Contrib Nephrol; 1980; 18():29-41. PubMed ID: 7353378
[No Abstract] [Full Text] [Related]
7. The role of vitamin D in renal bone disease.
Stanbury SW
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():25s-30s. PubMed ID: 342146
[No Abstract] [Full Text] [Related]
8. Treatment of renal osteodystrophy with calciferol (vitamin D) and related steroids.
Brickman AS; Norman AW
Kidney Int; 1973 Aug; 4(2):161-7. PubMed ID: 4364427
[No Abstract] [Full Text] [Related]
9. Management of metabolic bone disease.
Br Med J; 1969 Mar; 1(5644):621-3. PubMed ID: 5766131
[No Abstract] [Full Text] [Related]
10. Vitamin D compounds and renal osteodystrophy.
Felsenfeld AJ; Llach F
Int J Artif Organs; 1983 Nov; 6(6):281-4. PubMed ID: 6689416
[No Abstract] [Full Text] [Related]
11. [Anomalies of phosphorus-calcium metabolism in renal insufficiency. Value of the physiopathological diagnosis and therapy].
Hioco D; Dorfmann H; Chot ST; Bordier P; de Zèze S
Rev Rhum Mal Osteoartic; 1972 Oct; 39(10):617-25. PubMed ID: 5083698
[No Abstract] [Full Text] [Related]
12. Long-term effects of small doses of 1,25-dihydroxycholecalciferol in renal osteodystrophy.
Ahmed KY; Varghese Z; Wills MR; Meinhard EA; Moorhead JF
Lancet; 1978 Mar; 1(8065):629-32. PubMed ID: 76168
[TBL] [Abstract][Full Text] [Related]
13. The histopathology of porotic and malacic conditions of bone.
BAKER SL
Br J Radiol; 1954 Nov; 27(323):604. PubMed ID: 13209011
[No Abstract] [Full Text] [Related]
14. Vitamin D therapy: problems and prospects.
Drug Ther Bull; 1975 Apr; 13(8):29-31. PubMed ID: 165927
[No Abstract] [Full Text] [Related]
15. Experience with 1,25-dihydroxycholecalciferol therapy in undergoing hemodialysis patients with progressive vitamin D2-treated osteodystrophy.
Prior JC; Cameron EC; Ballon HS; Lirenman DS; Moriarty MV; Price JD
Am J Med; 1979 Oct; 67(4):583-9. PubMed ID: 386792
[TBL] [Abstract][Full Text] [Related]
16. The use of metabolites and analogues of vitamin D in prospective renal transplant recipients.
Cundy T; Kanis JA; Fraher L; Clemens TL; O'Riordan JL
Clin Nephrol; 1981 May; 15(5):240-5. PubMed ID: 7018772
[No Abstract] [Full Text] [Related]
17. [Treatment with 1-alpha hydroxy vitamin D3 of bone disease in hemodialysis. Therapeutic results and complications].
García de Vinuesa S; Barril G; Luño J; Alles A; Jofré R; Pérez García R; Olivas E; López Gómez JM; Valderrábano F
Rev Clin Esp; 1980 Dec; 159(5):317-22. PubMed ID: 7221095
[No Abstract] [Full Text] [Related]
18. Calcifediol (25-hydroxyvitamin D3) in the treatment of uremic bone disease.
Teitelbaum SL
Ann Intern Med; 1981 Mar; 94(3):404-5. PubMed ID: 6894359
[No Abstract] [Full Text] [Related]
19. Osteopenia: osteoporosis, osteomalacia and other forms of decreased mineralized bone mass.
Mundy GR; Canalis EM; Raisz LG
Conn Med; 1976 Nov; 40(11):753-7. PubMed ID: 975804
[No Abstract] [Full Text] [Related]
20. [Evolving aspects of uremic osteodystrophy in the dialized patient].
Zucchelli P; Fusaroli M; Fabbri L; Catizone L; Pavlica P; Viglietta G; Casanova S
J Urol Nephrol (Paris); 1976; 82(4-5):325-8. PubMed ID: 940176
[No Abstract] [Full Text] [Related]
[Next] [New Search]
